Acura Pharmaceuticals
(OTC) ACUR
Acura Pharmaceuticals Financials at a Glance
Market Cap
$660,000
Revenue (TTM)
$1.56M
Net Income (TTM)
$879.00K
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
10.00 (High)
Dividend
$0.00
Beta (Volatility)
10.00 (High)
Price
$0.01
Volume
50
Open
$0.01
Price
$0.01
Volume
50
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.00 - $0.02
Dividend
$0.00
Beta (Volatility)
10.00 (High)
Price
$0.01
Volume
50
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.00 - $0.02
ACUR News
Whoa! What Just Happened to My Stock?
3 Stocks to Get on Your Watchlist
This Week in Biotech
Why Acura Is Poised to Pull Back
The Dow Catches Its Breath
ACUR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Acura Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
9
CEO
Robert B. Jones, MBA
Website
www.acurapharm.comHeadquarters
Palatine, IL 60067, US
ACUR Financials
Key Financial Metrics (TTM)
Gross Margin
94%
Operating Margin
-78%
Net Income Margin
-56%
Return on Equity
0%
Return on Capital
-4%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$660.00K
Shares Outstanding
66.00M
Volume
50
Short Interest
0.00%
Avg. Volume
478.71
Financials (TTM)
Gross Profit
$1.47M
Operating Income
$1.21M
EBITDA
$589.00K
Operating Cash Flow
$742.00K
Capital Expenditure
$0.00
Free Cash Flow
$742.00K
Cash & ST Invst.
$65.00K
Total Debt
$200.00K
Acura Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$36.00K
-95.0%
Gross Profit
$9.00K
-98.7%
Gross Margin
25.00%
N/A
Market Cap
$660.00K
N/A
Market Cap/Employee
$73.33K
N/A
Employees
9
N/A
Net Income
$29.00K
+111.9%
EBITDA
$47.00K
+142.0%
Quarterly Fundamentals
Net Cash
$135.00K
+97.7%
Accounts Receivable
$158.00K
-74.8%
Inventory
$0.00
N/A
Long Term Debt
$167.00K
+59.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
-1.02%
N/A
Return on Invested Capital
-3.52%
N/A
Free Cash Flow
$426.00K
-432.5%
Operating Cash Flow
$426.00K
-432.5%